The translational research arm of Prostate Cancer Research (PCR).
Building on 30 years’ experience of prostate cancer research we combine seed funding, scientific expertise, patient voice and commercial experience to partner with companies with the goal to transform prostate cancer pathways.
Our strategy is focused on building a portfolio of promising companies that could impact prostate cancer, co-investing with venture capital funders and impact investors and connecting these companies to the resources and expert support they need to succeed.
Find out about the latest news and developments from Proven Connect.
What we do
Delivering innovation to prostate cancer patients through collaboration
Proven Connect can help you connect
Contact us right now and let’s start the journey together.